Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
11/1/1997
1.
Phase III Randomized Study of Remission Induction with VAD-P (VCR/DOX/DM/PRED) vs VAD-P/Q (VAD-P with Quinine) and of Remission Maintenance with Alternate-Day PRED (10 vs 50 mg) in Patients with Previously Untreated Multiple Myeloma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
adult
NCI
SWOG-9210
Last Modified:
11/1/1992
2.
Phase II Study of Risk-Adapted Chemotherapy in the Treatment of AIDS-Related and HTLV-I-Related non-Hodgkin's Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
AECM-9102039
NCI-V91-0109
Last Modified:
10/9/2007
3.
Phase II Study of CVAD (CTX/VCR/DOX/DM) with Verapamil/Quinine in Patients with Intermediate- and High-Grade non-Hodgkin's Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
15 and over
NCI
SWOG-9125
Last Modified:
12/1/1994
4.
Phase II Study of TAX with TAX/QUIN for TAX-Resistant Disease for non-Hodgkin's Lymphoma Refractory to Standard Chemotherapy (Summary Last Modified 12/94)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
UARIZ-HSC-92117
NCI-T92-0103D, T92-0103
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute